Clinical Trials Logo

Clinical Trial Summary

A pilot study investigating if orally administrated faecal microbiota transplantation capsules have the potential to treat active microscopic colitis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05998174
Study type Interventional
Source Hvidovre University Hospital
Contact
Status Not yet recruiting
Phase Early Phase 1
Start date September 2023
Completion date March 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05058131 - Modulation of Intestinal Barrier Function and Inflammation Via Butyrate-promoting Dietary Fibre N/A
Completed NCT02303132 - Ussing Experiments to Evaluate the Role of Medication-induced Microscopic Colitis N/A
Terminated NCT05579444 - Systems Biology of Gastrointestinal and Related Diseases
Recruiting NCT06031064 - External Validation of a Microscopic Colitis Clinical Scoring System in Patients With Chronic Watery Diarrhoea
Recruiting NCT04043897 - Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis Phase 2
Recruiting NCT06172647 - Mucosa Adherent Intestinal Microbiome in Microscopic Colitis and Colorectal Cancer
Recruiting NCT03477032 - FMT in Inflammatory Bowel Disease
Completed NCT03275467 - Faecal Microbiota Transplantation in Patients With Microscopic Colitis N/A
Completed NCT01928667 - Case-Control Study to Identify Risk Factors for Microscopic Colitis N/A
Completed NCT00180050 - Budesonide Treatment for Lymphocytic Colitis Phase 3
Not yet recruiting NCT05915104 - Efficacy and Safety of Budesonide MMX® vs. Budesonide CR for Induction of Remission in Microscopic Colitis Phase 2
Completed NCT00952952 - Trial of Mesalamine for the Treatment of Active Microscopic Colitis Phase 2/Phase 3